HEKKALA Anne | JDRF Center for Prevention of Type 1 Diabetes in Finland at the Universities of Turku

スポンサーリンク

概要

• HEKKALA Anneの詳細を見る
• 同名の論文著者
• JDRF Center for Prevention of Type 1 Diabetes in Finland at the Universities of Turkuの論文著者

関連著者

• Nanto-salonen Kirsti

  Jdrf Center For Prevention Of Type 1 Diabetes In Finland At The Universities Of Turku

• Knip Mikael

  Jdrf Center For Prevention Of Type 1 Diabetes In Finland At The Universities Of Turku

• Knip Mikael

  University Of Helsinki

• Ilonen Jorma

  Jdrf Center For Prevention Of Type 1 Diabetes In Finland At The Universities Of Turku

• Ilonen Jorma

  Turku Immunology Centre And Department Of Virology University Of Turku

• Simell Olli

  Jdrf Center For Prevention Of Type 1 Diabetes In Finland At The Universities Of Turku

• Simell Satu

  Jdrf Center For Prevention Of Type 1 Diabetes In Finland At The Universities Of Turku

• Simell Tuula

  Jdrf Center For Prevention Of Type 1 Diabetes In Finland At The Universities Of Turku

• HYOTY Heikki

  JDRF Center for the Prevention of Type 1 Diabetes in Finland

• ILONEN Jorma

  University of Turku

• HEKKALA Anne

  JDRF Center for Prevention of Type 1 Diabetes in Finland at the Universities of Turku

• Hyoty Heikki

  Jdrf Center For Prevention Of Type 1 Diabetes In Finland At The Universities Of Turku

• Knip Mikael

  Jdrf Center For The Prevention Of Type 1 Diabetes In Finland

• HYOTY Heikki

  Department of Virology, Medical School, University of Tampere

• Simell Ville

  Jdrf Center For Prevention Of Type 1 Diabetes In Finland At The Universities Of Turku

• SILJANDER Heli

  JDRF Center for Prevention of Type 1 Diabetes in Finland at the Universities of Turku

• LEHTIHUHTA Erkka

  JDRF Center for Prevention of Type 1 Diabetes in Finland at the Universities of Turku

• SILEN Paivi

  JDRF Center for Prevention of Type 1 Diabetes in Finland at the Universities of Turku

• ILOLA Anna-Marja

  JDRF Center for Prevention of Type 1 Diabetes in Finland at the Universities of Turku

• LAHDE Jyrki

  JDRF Center for Prevention of Type 1 Diabetes in Finland at the Universities of Turku

もっと見る 閉じる

著作論文

• FEASIBILITY OF A PLACEBO-CONTROLLED DOUBLE-BLINDED TYPE 1 DIABETES (T1D) PREVENTION TRIAL TESTING EFFICACY OF NASAL INSULIN IN A POPULATION-BASED COHORT OF CHILDREN WITH HLA-CONFERRED T1D RISK AND MULTIPLE AUTOANTIBODIES
• THE RATE OF EMERGENCE OF AUTOANTIBODIES IS STABLE BETWEEN 6 MONTHS AND AT LEAST 8 YEARS OF AGE BUT DEPENDS ON HLA-CONFERRED RISK IN A PROSPECTIVELY FOLLOWED-UP POPULATION-BASED BIRTH COHORT

スポンサーリンク